CASE REPORT
A 31-year-old woman (gravida 3, para 0) presented to hospital in established labour at 34 weeks' gestation with a twin pregnancy. The first twin was a breech presentation. Type 1 congenital antithrombin III deficiency had been diagnosed shortly before she became pregnant. Past medical history included a deep venous thrombosis of the leg while using oral contraceptives nine years previously. She was allergic to penicillin (generalized urticaria) and claimed to be allergic to general anaesthetics, having been admitted to hospital for two days with generalized swelling of the body and face after a general anaesthetic for a miscarriage 14 months previously. This operation had been performed elsewhere and no records were available. She neither knew which drugs had been administered nor had she been investigated postoperatively. During the current pregnancy a large left ovarian cyst had been discovered.
In consultation with a haematologist, subcutaneous heparin therapy had been started at the end of the first trimester and increased to 10,000 units b.d. at 30 weeks' gestation. A satisfactory elevation of APPT levels (i.e. >55s) had been achieved with this regimen, apparently. Heparin had last been injected eight hours prior to admission. She was obese (89 kg). The activated partial thromboplastin time (APPT) was 36.1s (control 34.4s, range 35-43s) and the platelet count was normal.
The obstetrician decided to perform an urgent caesarean section with left ovarian cystectomy. Antithrombin III concentrate was not available and so it was planned to give intravenous heparin for two days after operation and to start oral warfarin for six weeks.
The patient declined a general anaesthetic citing her previous allergy. Caesarean section with ovarian cystectomy was performed under continuous lumbar epidural anaesthesia using 2% lignocaine with adrenaline 1:200,000 and epidural fentanyl 100 p.g via an epidural catheter. The epidural was inserted uneventfully using the loss-of-resistance-to-saline technique with the patient positioned in the left lateral decubitus position. Pneumatic leggings and antiembolism stockings (Kendall HeaIthcare Products, Mansfield, U.S.A.) were used during the operation and 500 ml Dextran 70 given. Live male twins were delivered. The operation lasted two hours and the estimated blood loss of one litre was replaced with an additional litre of crystalloid solution. Two epidural top-ups of 4 ml2% lignocaine with 1:200,000 adrenaline were given intraoperatively. The APPT was measured at the end of the operation (44s) and the epidural catheter was then removed.
Postoperative analgesia was provided by intravenous patient controlled analgesia with pethidine supplemented by oral sodium diclofenac 100 mg. Three hours after operation an intravenous bolus of 2000 U heparin was given followed by an IV infusion of 1000 to 1200 U/hr maintaining the APTT above 55s. The patient was mobilized from bed on the first postoperative day. Oral warfarin was started on the second day and continued for six weeks. Neurological function was monitored for three days without revealing any sequelae. There were no thrombotic or haemorrhagic complications in the puerperium.
DISCUSSION
Antithrombin III is a serine proteinase inhibitor and the main in vivo inhibitor of coagulation. Principally, it inactivates thrombin and to a lesser extent factors IXa, Xa, XIa and XIla. Heparin requires the presence of AT-Ill to be effective and catalyses the actions of AT-III by binding to it. Laboratory diagnosis of AT-Ill is made by an immunoassay of AT-Ill levels and by an assay of its functional activity and heparin co-factor activity. Platelet count, activated partial thromboplastin time, prothrombin time, thrombin time, bleeding time and levels of other coagulation factors are all normaP. Three types of AT-Ill deficiency are described. In type I there is a deficiency of structurally normal AT-Ill. In type 11 there are normal levels of functionally deficient AT-Ill. In type III deficiency the ability of AT-III to bind heparin is reduced or lost. The prevalence of thrombosis is 521l7o in type I, 541l7o in type 11 and 61l7o in type III!.
Lifelong oral anticoagulant treatment is indicated for those with proven thrombosis. In asymptomatic carriers the benefits of.prophylaxis have to be weighed against the risks of haemorrhage and the issue is controversial. Some advocate prophylaxis for asymptomatic carriers 4 while others maintain that such treatment does not reduce mortality56. A case has been made for prophylaxis between 15 and 40 years age when the risk of thrombosis is greatest and haemorrhage rarely fatal. Prophylaxis is advocated in all AT-Ill deficient subjects in situations of increased thrombotic risk, e.g. surgery, pregnancy, leg trauma! 5. 6 • Delivery is a time of both haemorrhagic and thrombotic risk. Various prophylactic regimens for pregnancy and delivery have been described; heparin alone 79 , AT-Ill concentrate alone!O, heparin with AT-Ill at delivery'"!'. Therapy with heparin alone is safe and effective 8 . 9 provided that the trough APTT is prolonged by at least lOs'. There would be no added haemorrhagic risk from therapy, if prior to delivery the APTT were normalized by reducing subcutaneous heparin and AT-Ill concentrate used"!!. Although warfarin is generally contraindicated in the first trimester due to teratogenicity, there are reports of its successful use in combination with heparin l2 ,!], heparin and AT-Ill concentrate", or alone in low dosage l4
• AT-lII concentrate should be used for prophylaxis in type III deficiency, since heparin cannot complex with the abnormal AT-lII module and produce an anticoagulant effect!,7. AT-Ill concentrate has a biological half-life of about 2.5 days in congenital AT-Ill deficiency and a regimen to maintain functional AT-Ill levels above 80% of normal is recommended'. AT-Ill concentrate is prepared from pooled human plasma and pasteurized to inactivate HIVI and hepatitis viruses].
Reports of caesarean section in this condition are rare. A search of the recent English literature (MEDLINE 1984-94, Antithrombin III deficiency) revealed only five cases, none of which provided details of the anaesthetic technique used. In three instances patients were managed with AT-III concentrate and Dextran 70 215 , in one with Dextran 70 only" and one with subcutaneous heparin only7. There were no thromboembolic or haemorrhagic complications in any of these cases. Prophylactic use of AT-Ill concentrate in patients undergoing surgery is recommended and supported by retrospective reports". Although AT-III concentrate was not used in this case, it should be noted that AT-Ill concentrate enhances the anticoagulant effect of heparin',!9. Had AT-III concentrate been available, it could have been given after performing the epidural and after allowing time for any occult bleeding within the epidural space to stop.
The risk of epidural haematoma due to regional anaesthesia in this patient was considered to be very low. Owing to the short half-life of heparin, regional anaesthesia in the presence of heparin prophylaxis is not contraindicated, provided the procedure is not performed within 4 to 6 hours of heparin administration!6,[7 and the coagulation screen is normal (platelets > 100,000 x 10 9 /1, PT and APTT < 1.5 x control)'7,\8.
A PTT of 42s (control 34s) was considered a contraindication to epidural analgesia in one patient with AT-IlI deficiency treated with subcutaneous heparin alone!9. Presumably, regional analgesia would not be contraindicated when AT-Ill concentrate alone was used at delivery.
AT-Ill levels and activity fall to their lowest post partum, which is the time of greatest thrombotic risk iJ • In addition, high dose heparin therapy further reduces AT-Ill levels!' and this increases the risk of thrombosis if heparinization is inadequate'. If heparin has been discontinued prior to delivery and AT-Ill concentrate not used, heparin therapy should be restarted within 2 to 6 hours of delivert,'J.
Lignocaine 21l7o with adrenaline 1:200,000 was preferred to bupivacaine 0.51l7o so that the epidural block would regress rapidly and not mask the potential formation of an epidural haematoma when heparin was being resumed. The three-hour interval between removing the epidural catheter and restarting heparin was considered sufficient to allow any occult bleeding in the epidural space to stop.
The patient's medical notes relating to the anaesthetic allergy were later retrieved. It transpired that during that operation she had been given penicillin for a second time. This seemed a more likely explanation of her alleged anaesthetic allergy than the propofol and fentanyl which had been used. She was told of this and of which anaesthetic drugs had been used.
While this patient was managed without complication, this report highlights the need for consultation between haematologist, obstetrician and anaesthetist.
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